Prognosis of Human Cytomegalovirus in Cancer Patients Undergoing Chemotherapeutic Treatment in Egypt and an Emergent Prevalence of Glycoprotein B-5

Prognosis of Human Cytomegalovirus in Cancer Patients Undergoing Chemotherapeutic Treatment in Egypt and an Emergent Prevalence of Glycoprotein B-5

The human cytomegalovirus (HCMV) is a global opportunistic β-herpes virus causing severe diseases in immune-compromised patients, such as malignant tumor patients, especially those undergoing chemotherapeutic treatment. This study aimed to determine the prevalence of HCMV-DNA in chemotherapeutic tre...

Full description

Bibliographic Details
Main Authors: Israa S. Shamsia, Rania Abozahra, Kholoud Baraka, Ayman Abou Shmeila, Sarah M. Abdelhamid
Format: Article
Language:English
Published: Journal of Pure and Applied Microbiology 2022-12-01
Series:Journal of Pure and Applied Microbiology
Subjects:
human cytomegalovirus
genotyping
cancer
elisa
nested pcr
Online Access:https://microbiologyjournal.org/prognosis-of-human-cytomegalovirus-in-cancer-patients-undergoing-chemotherapeutic-treatment-in-egypt-and-an-emergent-prevalence-of-glycoprotein-b-5/

Internet

https://microbiologyjournal.org/prognosis-of-human-cytomegalovirus-in-cancer-patients-undergoing-chemotherapeutic-treatment-in-egypt-and-an-emergent-prevalence-of-glycoprotein-b-5/

Similar Items